KLK3 and neoplasm: As a result, assessing prognostic factors is pivotal for stratifying PCa clinical risk categories; accordingly, although unfavorable tumor grades and PSA dynamics in treated patients predict PCa progression and survival, instead multilevel nomograms including several clinical risk factors have been suggested as the way forward [18,19].